Decreasing Morbidity through Exposure to the Prostate Biopsy Gun and Distraction during Prostate Biopsy

Overview

About this study

This study will attempt to identify potential non-pharmacologic interventions that will decrease the morbidity associated with prostate biopsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Men will be eligible for this study if they were referred for a non-saturation office prostate biopsy to rule out the presence of prostate cancer in the setting of an elevated PSA or abnormal DRE. These men will be identified from the prostate biopsy schedule and from those added to the schedule that day. There are no age restrictions, though likely the age range will go from 40-80 yrs. Health status will not be separately evaluated, but rather deemed adequate for men healthy enough to undergo prostate biopsy.

Inclusion Criteria:

Men will be eligible for this study if they were referred for a non-saturation office prostate biopsy to rule out the presence of prostate cancer in the setting of an elevated PSA or abnormal DRE. These men will be identified from the prostate biopsy schedule and from those added to the schedule that day.

Exclusion Criteria:

Exclusion criteria will include patients with: hearing impairment, previous biopsies, history of daily narcotic use, chronic prostatitis and chronic pelvic pain, pelvic floor tension myalgia, and other chronic pain syndromes, active anorectal disease, anxiety, depression and active urinary tract infection. Patients will also need to be proficient in English, with at least a 6th grade reading level.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Lance Mynderse, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Lance Mynderse, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials